Properties and benefits investigated
Short-acting GHRH-pathway research and GH-axis signaling. No DAC lacks the drug-affinity complex; prolonged GH/IGF-1 results from long-acting CJC-1295 must not be attributed to this formulation.
AVITUS RESEARCHCJC-1295 No DAC
GH Secretagogues
CJC-1295 No DAC
Short-acting GHRH analog studied for growth-hormone-axis signaling.
- Research category
- GH Secretagogues
- Intended context
- Laboratory research only
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Evidence and limitations
Compound identity, formulation and limited direct evidence require careful distinction from related molecules. No therapeutic benefit is established for this catalogue product.
References
PMID: 16352683
Product specifications.
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.